Atlas Trials

Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

Clinical trial NCT05218356 · RECRUITING

Trial details

NCT number
NCT05218356
Sponsor
Code Pharma
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2022-01-20
Primary completion
2024-12-20
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.